154 related articles for article (PubMed ID: 1314830)
1. Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor.
Thigpen AE; Russell DW
J Biol Chem; 1992 Apr; 267(12):8577-83. PubMed ID: 1314830
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
[TBL] [Abstract][Full Text] [Related]
3. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes.
Thigpen AE; Cala KM; Russell DW
J Biol Chem; 1993 Aug; 268(23):17404-12. PubMed ID: 8394341
[TBL] [Abstract][Full Text] [Related]
5. Finasteride: a slow-binding 5 alpha-reductase inhibitor.
Faller B; Farley D; Nick H
Biochemistry; 1993 Jun; 32(21):5705-10. PubMed ID: 8389191
[TBL] [Abstract][Full Text] [Related]
6. Determination of rat 5alpha-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines.
Szécsi M; Ondré D; Tóth I; Magony S; Wölfling J; Schneider G; Julesz J
Acta Biol Hung; 2010 Sep; 61(3):274-81. PubMed ID: 20724274
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition.
Azzolina B; Ellsworth K; Andersson S; Geissler W; Bull HG; Harris GS
J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):55-64. PubMed ID: 9328210
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.
Délos S; Iehlé C; Martin PM; Raynaud JP
J Steroid Biochem Mol Biol; 1994 Mar; 48(4):347-52. PubMed ID: 8142312
[TBL] [Abstract][Full Text] [Related]
9. Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase.
George FW; Russell DW; Wilson JD
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8044-7. PubMed ID: 1654556
[TBL] [Abstract][Full Text] [Related]
10. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression and functional characterization of type 1 and type 2 steroid 5 alpha-reductases from Cynomolgus monkey: comparisons with human and rat isoenzymes.
Levy MA; Brandt M; Sheedy KM; Holt DA; Heaslip JI; Trill JJ; Ryan PJ; Morris RA; Garrison LM; Bergsma DJ
J Steroid Biochem Mol Biol; 1995 Apr; 52(4):307-19. PubMed ID: 7734398
[TBL] [Abstract][Full Text] [Related]
12. The clinical development of a 5 alpha-reductase inhibitor, finasteride.
Stoner E
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):375-8. PubMed ID: 1701660
[TBL] [Abstract][Full Text] [Related]
13. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review.
Imperato-McGinley J
Eur Urol; 1991; 20 Suppl 1():78-81. PubMed ID: 1722167
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions.
Normington K; Russell DW
J Biol Chem; 1992 Sep; 267(27):19548-54. PubMed ID: 1527072
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
Makridakis N; Reichardt JK
J Mol Endocrinol; 2005 Jun; 34(3):617-23. PubMed ID: 15956333
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
[TBL] [Abstract][Full Text] [Related]
18. FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects.
Giudici D; Briatico G; Cominato C; Zaccheo T; Iehlè C; Nesi M; Panzeri A; di Salle E
J Steroid Biochem Mol Biol; 1996 Jun; 58(3):299-305. PubMed ID: 8836165
[TBL] [Abstract][Full Text] [Related]
19. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
Diani AR; Mulholland MJ; Shull KL; Kubicek MF; Johnson GA; Schostarez HJ; Brunden MN; Buhl AE
J Clin Endocrinol Metab; 1992 Feb; 74(2):345-50. PubMed ID: 1309834
[TBL] [Abstract][Full Text] [Related]
20. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition.
Rhodes L; Primka RL; Berman C; Vergult G; Gabriel M; Pierre-Malice M; Gibelin B
Prostate; 1993; 22(1):43-51. PubMed ID: 8381228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
